The survey was conducted by Health Catalyst and queried CIOs, CMIOs and CMOs of health systems. Notable findings included:
- 59 percent of respondents said precision medicine will not play a significant role in their organization in the next five years.
- 68 percent of respondents said precision medicine will play a non-existent, small or average role in their organizations between now and 2020.
- 63 percent of respondents said their organizations had no plans to integrate genomic data into their EHRs, although 50 percent agree genomic data could have a positive impact on their patient treatment strategies.
- 71 percent of respondents from academic medical centers said precision medicine would play a significant role in their organizations in the next five years.
- 64 percent of respondents from academic medical centers they plan to integrate genomic data into their EHRs.
More articles on health IT:
Senate won’t take up 21st Century Cures bill
Stanford Medicine dean: Instead of precision medicine, let’s focus on precision health
Why interoperability still eludes healthcare: Q&A with Dr. Charles Jaffe, CEO of HL7
